Target intelligence / Profile preview

CKAP2 divergent transcript (CKAP2-DT)

Target
CKAP2-DT
Molecular classification
Other (Long non-coding RNA, divergent transcript)
01

Overview

CKAP2 divergent transcript (CKAP2-DT) is a long non-coding RNA (lncRNA) gene located near the CKAP2 locus on human chromosome 13. Divergent transcripts are a class of lncRNAs transcribed in the opposite direction from nearby protein-coding genes within a short genomic distance (typically within 300-500 base pairs). The specific biological role and disease association of CKAP2-DT have not been thoroughly characterized in publicly available literature; it is primarily annotated as a genomic feature without clear evidence as a therapeutic target or established biomarker. This distinguishes it from the protein-coding gene CKAP2 (cytoskeleton associated protein 2), which is involved in microtubule stabilization, cell division, and has been studied as a biomarker and mechanistic contributor to several diseases, including cancer and rheumatoid arthritis. If you are seeking information on the protein-coding gene CKAP2, it is a distinct entity from CKAP2-DT. CKAP2-DT as a divergent transcript does not code for a protein and does not currently meet criteria for a druggable therapeutic target.

Other names
CKAP2-DTENSG00000278238123706541
02

Biological functions

Not well characterizedDivergent transcripts are generally involved in regulation of gene expression, possibly chromatin modification or transcriptional regulation
03

Disease associations

Other (currently, no direct disease linkage established in public sources for CKAP2-DT, but related protein-coding gene CKAP2 has roles in cancer and inflammation)

Beyond the preview

Go deeper on CKAP2 divergent transcript (CKAP2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CKAP2 divergent transcript (CKAP2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call